Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.
Chicago, IL – December 5, 2024 – Today, Zacks Equity Research discusses ResMed RMD, Haemonetics HAE, Phibro Animal Health PAHC and Agios Pharmaceuticals AGIO. Industry: Medical Products Link ...
Learn More If you've been paying attention to ResMed Inc (ASX ... competing line of continuous positive airway pressure (CPAP) machines, which are used to manage OSA. Looking forward, analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results